Carl-Johan Dalsgaard
Directeur Général chez BioFactor Therapeutics AB
Fortune : 786 479 $ au 30/04/2024
Postes actifs de Carl-Johan Dalsgaard
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BioFactor Therapeutics AB | Directeur Général | 14/08/2009 | - |
CePeP AB
 CePeP AB Miscellaneous Commercial ServicesCommercial Services CePeP AB provides pharmaceutical research and development services. Its cell penetrating peptides are used for treatment of cancer and endocrine disorders. The company was founded in November 2001 and is headquartered in Stockholm, Sweden. | Directeur Général | 14/08/2009 | - |
| BioCrine AB | Directeur Général | 14/08/2009 | - |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Private Equity Investor | 03/08/2010 | - |
| Healthcap IV GP SA | Corporate Officer/Principal | - | - |
Healthcap IV GP AB
 Healthcap IV GP AB Financial ConglomeratesFinance Part of Odlander, Fredrikson & Co. AB, Healthcap IV GP AB is a Swedish company that provides investment services. The company is based in Sundsvall, Sweden. | Corporate Officer/Principal | - | - |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Directeur/Membre du Conseil | - | - |
| Directeur Général | - | - |
Historique de carrière de Carl-Johan Dalsgaard
Anciens postes connus de Carl-Johan Dalsgaard
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| VICORE PHARMA HOLDING AB | Directeur Général | 01/09/2018 | 09/09/2023 |
| Investor Relations Contact | 01/09/2018 | 09/09/2023 | |
| Public Communications Contact | 01/09/2018 | - | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | President | - | - |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - | - |
| ░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ | - | - | |
| ░░░░░░░░░ ░░░░░░░░░░ ░ ░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░ ░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - | |
| ░░░░░ ░░░░ ░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formation de Carl-Johan Dalsgaard
| Karolinska Institutet | Doctorate Degree |
| Harvard Medical School | Doctorate Degree |
Statistiques
Internationale
| Suède | 19 |
| Etats-Unis | 3 |
| Suisse | 2 |
Opérationnelle
| Chief Executive Officer | 9 |
| Corporate Officer/Principal | 5 |
| Director/Board Member | 4 |
Sectorielle
| Health Technology | 9 |
| Finance | 5 |
| Commercial Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TENGION, INC. | Health Technology |
| VICORE PHARMA HOLDING AB | Health Technology |
| Entreprise privées | 17 |
|---|---|
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Health Technology |
RSPR Pharma AB
 RSPR Pharma AB Pharmaceuticals: MajorHealth Technology RSPR Pharma AB develops therapeutics for inflammatory vascular diseases. The firm's products are used to treat diseases such as atherosclerosis and abdominal aortic aneurysm. The company was founded by Carl-Johan Dalsgaard in 2006 and is headquartered in Stockholm, Sweden. | Health Technology |
| BioFactor Therapeutics AB | |
CePeP AB
CePeP AB Miscellaneous Commercial ServicesCommercial Services CePeP AB provides pharmaceutical research and development services. Its cell penetrating peptides are used for treatment of cancer and endocrine disorders. The company was founded in November 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
| BioCrine AB | |
Odlander, Fredrikson & Co. AB
 Odlander, Fredrikson & Co. AB Financial ConglomeratesFinance Odlander Fredrikson & Co. AB provides financial support services. The company was founded in 1996 and is headquartered in Stockholm, Sweden. | Finance |
Astra AB
 Astra AB Pharmaceuticals: MajorHealth Technology Astra AB used to manufacture and market cardiovascular preparations, local anesthetics, anti-infective agents and medical-care equipment. The firm's products were Pulmicort, Xylocaine, Marcaine, EMLA and Naropin. It had operations in Scandinavia, Europe, North & South America, Australia, New Zealand, Africa and Asia. The company was headquartered in Södertälje, Sweden. | Health Technology |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
LTB4 Sweden AB
 LTB4 Sweden AB BiotechnologyHealth Technology LTB4 Sweden AB engages in research and product development related to antimicrobial and anti-inflammatory substances through its subsidiaries. The company was founded by Bengt Ingemar Samuelsson on February 26, 2004 and is headquartered in Stockholm, Sweden. | Health Technology |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |
HealthCap AB
HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Finance |
| Healthcap IV GP SA | |
Healthcap IV GP AB
Healthcap IV GP AB Financial ConglomeratesFinance Part of Odlander, Fredrikson & Co. AB, Healthcap IV GP AB is a Swedish company that provides investment services. The company is based in Sundsvall, Sweden. | Finance |
INIM Pharma AB
 INIM Pharma AB Pharmaceuticals: MajorHealth Technology INIM Pharma AB operates as drug development company that focuses on the development of immunomodulatory drugs for interstitial lung diseases. It develops a new local treatment for severe rare lung diseases such as idiopathic pulmonary fibrosis. The company was founded by Carl-Johan Dalsgaard and is headquartered in Stockholm, Sweden. | Health Technology |
| Astra Pain Control AB | |
Vicore Pharma AB
Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Health Technology |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Finance |
- Bourse
- Insiders
- Carl-Johan Dalsgaard
- Expérience